Arslan_2022_Biomolecules_12_

Reference

Title : Cholinesterase Deficiency Syndrome-A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson's Disease - Arslan_2022_Biomolecules_12_
Author(s) : Arslan M , Novak M , Rosenthal D , Hartmann CJ , Albrecht P , Samadzadeh S , Hefter H
Ref : Biomolecules , 12 : , 2022
Abstract :

A family is described as having two recessively inherited metabolic diseases and three differently affected children. During the explantation of a drain tube grommet under general anesthesia, a prolonged resuscitation and wake-up period occurred in the key case when he was 8 years old. This led to a family screening for butyrylcholinesterase deficiency, which was confirmed not only in the key case but also in his 5-year-old sister; it was not confirmed in his 10-year-old brother. However, the key case not only had reduced serum levels of BCHE, but also elevated liver enzyme levels, which are atypical for BCHE deficiency. After the exclusion of viral and autoimmune hepatitis, Wilson's disease (WD) was eventually diagnosed and also confirmed in his elder brother, but not in his sister. This family is presented to highlight an extremely rare WD-patient in whom a low serum level of BCHE did not occur because of WD but because of BCHE deficiency.

PubMedSearch : Arslan_2022_Biomolecules_12_
PubMedID: 36291607

Related information

Citations formats

Arslan M, Novak M, Rosenthal D, Hartmann CJ, Albrecht P, Samadzadeh S, Hefter H (2022)
Cholinesterase Deficiency Syndrome-A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson's Disease
Biomolecules 12 :

Arslan M, Novak M, Rosenthal D, Hartmann CJ, Albrecht P, Samadzadeh S, Hefter H (2022)
Biomolecules 12 :